Deals that make sense, don't get us in trouble, and uphold our mission and principles
including over $800M in Industry Sponsored Research and over $250M in Licensing Revenue.
from discoveries licensed through IPIRA such as of treatment for malaria and cancer, biofuels, robotic legs, DNA sequencing, surgical tools, forensic tools, handheld diagnostics, gene editing, mobile microscopy, nanowires, RFID, internet security software, search engines and more.
to commercialize inventions and copyrights under licenses from IPIRA, attracting $1.6B in venture funding and $51M in SBIR/STTR grants since 2005. 29 Startups have had a successful exit via merger or acquisition, totaling in $8.1B in cash and stock options, while 66 Berkeley startups currently in the Bay Area employ 1,543 Californians & generate $195M in annual revenue.
through negotiated agreements with IPIRA, including $500M in industry sponsored research from British Petroleum for the Energy Biosciences Institute, >$5M in industry sponsored research from Aduro, and $89M in licensing revenue from Bristol-Myers Squibb.
including the Energy Biosciences Institute, California Research Alliances, Innovative Genomics Institute, & the Immunotherapeutics and Vaccine Research Initiative
UC Berkeley has the 2nd highest percentage of industry sponsored research when compared to other research institutions. Click on a link below to view one of the many success stories that IPIRA has helped create.